Outlook Therapeutics (OTLK) Gross Profit: 2015-2024
Historic Gross Profit for Outlook Therapeutics (OTLK) over the last 8 years, with Sep 2024 value amounting to -$3.2 million.
- Outlook Therapeutics' Gross Profit fell 100.33% to -$19,031 in Q3 2020 from the same period last year, while for Sep 2020 it was -$1.8 million, marking a year-over-year decrease of 121.56%. This contributed to the annual value of -$3.2 million for FY2024, which is 24.72% down from last year.
- As of FY2024, Outlook Therapeutics' Gross Profit stood at -$3.2 million, which was down 24.72% from -$2.5 million recorded in FY2023.
- Outlook Therapeutics' Gross Profit's 5-year high stood at -$1.8 million during FY2020, with a 5-year trough of -$3.2 million in FY2024.
- Moreover, its 2-year median value for Gross Profit was -$2.8 million (2023), whereas its average is -$2.8 million.
- Data for Outlook Therapeutics' Gross Profit shows a maximum YoY crashed of 121.56% (in 2020) over the last 5 years.
- Yearly analysis of 3 years shows Outlook Therapeutics' Gross Profit stood at -$1.8 million in 2020, then reached -$2.5 million in 2023, then declined by 24.72% to -$3.2 million in 2024.